{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:28:36Z","timestamp":1757629716287,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clgc.2025.102413","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:37:24Z","timestamp":1754437044000},"page":"102413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database Study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6601-1244","authenticated-orcid":false,"given":"Andrea","family":"Piccolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-6049","authenticated-orcid":false,"given":"Stephan M.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Brin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1255-9337","authenticated-orcid":false,"given":"Hanna","family":"Zurl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-2693","authenticated-orcid":false,"given":"Boyuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00f2 M.","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-0951","authenticated-orcid":false,"given":"Mutlay","family":"Sayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-8529","authenticated-orcid":false,"given":"Alexander P.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2025.102413_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clgc.2025.102413_bib0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102413_bib0003","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JU.0000000000002854","article-title":"Clinically localized Prostate cancer: AUA\/ASTRO guideline","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102413_bib0004","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.juro.2010.10.057","article-title":"Predicting 15-year prostate cancer specific mortality after radical prostatectomy","volume":"185","author":"Eggener","year":"2011","journal-title":"Journal of Urology"},{"key":"10.1016\/j.clgc.2025.102413_bib0005","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. EAU Guidelines Office, Arnhem, The Netherlands. ISBN 978-94-92671-29-5. Available at: http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/."},{"issue":"6","key":"10.1016\/j.clgc.2025.102413_bib0006","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102413_bib0007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2018.04.017","article-title":"Impact of adjuvant radiotherapy in node-positive prostate cancer patients: the importance of patient selection","volume":"74","author":"Abdollah","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102413_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13014-019-1384-z","article-title":"The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis","volume":"14","author":"Tao","year":"2019","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102413_bib0009","doi-asserted-by":"crossref","first-page":"220.e1","DOI":"10.1016\/j.urolonc.2024.03.015","article-title":"Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium","volume":"42","author":"Triner","year":"2024","journal-title":"Urol Oncol: Sem Origin Investigat"},{"issue":"5","key":"10.1016\/j.clgc.2025.102413_bib0010","doi-asserted-by":"crossref","first-page":"252.e9","DOI":"10.1016\/j.urolonc.2023.01.011","article-title":"Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations","volume":"41","author":"Nguyen","year":"2023","journal-title":"Urol Oncol: Sem Origin Investigat"},{"issue":"11","key":"10.1016\/j.clgc.2025.102413_bib0011","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pros.24552","article-title":"Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival","volume":"83","author":"Frego","year":"2023","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.clgc.2025.102413_bib0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41391-018-0083-4","article-title":"Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer","volume":"22","author":"Krimphove","year":"2019","journal-title":"Prostate Can Prostatic Dis"},{"issue":"4","key":"10.1016\/j.clgc.2025.102413_bib0013","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41391-024-00815-1","article-title":"Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer","volume":"27","author":"George","year":"2024","journal-title":"Prostate Can Prostatic Dis"},{"issue":"2","key":"10.1016\/j.clgc.2025.102413_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54559","article-title":"Association of academic Medical center presence with clinical outcomes at neighboring community hospitals among Medicare beneficiaries","volume":"6","author":"Burke","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.clgc.2025.102413_bib0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urolonc.2017.08.008","article-title":"Secondary data sources for health services research in urologic oncology","volume":"36","author":"Cole","year":"2018","journal-title":"Urol Oncol: Sem Origin Investigat"},{"issue":"35","key":"10.1016\/j.clgc.2025.102413_bib0016","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2013.54.7893","article-title":"Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer","volume":"32","author":"Abdollah","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102413_bib0017","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-5347(01)61640-9","article-title":"Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ Prostate Cancer: A Matched Comparison","volume":"161","author":"Ghavamian","year":"1999","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102413_bib0018","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2025.102413_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1281432","article-title":"Unraveling the safety of adjuvant radiotherapy in prostate cancer: impact of older age and hypofractionated regimens on acute and late toxicity - a multicenter comprehensive analysis","volume":"13","author":"Buwenge","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102413_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25728","article-title":"Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis","volume":"10","author":"Cui","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.clgc.2025.102413_bib0021","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bju.13679","article-title":"Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy","volume":"119","author":"Tilki","year":"2017","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.clgc.2025.102413_bib0022","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/cancers15112962","article-title":"Treating primary node-positive prostate cancer: a scoping review of available treatment options","volume":"15","author":"Zuur","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clgc.2025.102413_bib0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2018.04.017","article-title":"Impact of adjuvant radiotherapy in node-positive prostate cancer patients: the importance of patient selection","volume":"74","author":"Abdollah","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102413_bib0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41391-022-00619-1","article-title":"Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy","volume":"27","author":"Schaufler","year":"2024","journal-title":"Prostate Can Prostatic Dis"},{"key":"10.1016\/j.clgc.2025.102413_bib0025","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.21.02800","article-title":"Adjuvant versus early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer and the risk of death","volume":"40","author":"Tilki","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102413_bib0026","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14241","article-title":"Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit","volume":"123","author":"Gupta","year":"2019","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.clgc.2025.102413_bib0027","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.juro.2018.10.024","article-title":"Quality of care in the treatment of localized intermediate and high risk prostate cancer at minority serving hospitals","volume":"201","author":"Krimphove","year":"2019","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102413_bib0028","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.28617","article-title":"Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period","volume":"120","author":"Aizer","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102413_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amepre.2023.08.005","article-title":"Racial disparities in prostate cancer screening: the role of shared decision making","volume":"66","author":"Frego","year":"2024","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.clgc.2025.102413_bib0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.juro.2017.12.048","article-title":"Contemporary incidence and outcomes of prostate cancer lymph node metastases","volume":"199","author":"Bernstein","year":"2018","journal-title":"Journal of Urology"},{"issue":"8","key":"10.1016\/j.clgc.2025.102413_bib0031","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1470-2045(21)00242-4","article-title":"Elective nodal radiotherapy in prostate cancer","volume":"22","author":"De Meerleer","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:26:38Z","timestamp":1757517998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1558767325001132"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102413","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102413"}}